Immunogenicity and safety of monovalent and bivalent SARS-CoV-2 variant adapted RBD-based protein booster vaccines in adults previously immunized with different vaccine platforms: A phase II/III, randomized clinical trial
Titel:
Immunogenicity and safety of monovalent and bivalent SARS-CoV-2 variant adapted RBD-based protein booster vaccines in adults previously immunized with different vaccine platforms: A phase II/III, randomized clinical trial
Auteur:
Perez Marc, Gonzalo Coria, Lorena M. Ceballos, Ana Rodriguez, Juan Manuel Lombardo, Mónica E. Bruno, Laura Páez Córdoba, Federico Fascetto Cassero, Clara G. Salvatori, Melina Rios Medrano, Mayra Fulgenzi, Fabiana Alzogaray, María F. Mykietiuk, Analía Uriarte, Ignacio Leandro Itcovici, Nicolás Smith Casabella, Tomás Corral, Gonzalo Bruno, Miriam Roldán, Oscar Núñez, Sebastián A. Cahn, Florencia Yerino, Gustavo A. Bianchi, Alejandra Braem, Virginia Christmann, Analía Corradetti, Santiago Darraidou, Martín C. Di Nunzio, Lucila Estrada, Tatiana López Castelo, Rocío Marchionatti, Carla Pitocco, Lucila Trias Uriarte, Virgina Wood, Cristian Zadoff, Romina Bues, Florencia Garrido, Rosa M. Montomoli, Emanuele Manenti, Alessandro Demaría, Agostina Prado, Lineia Pueblas Castro, Celeste Saposnik, Lucas Geffner, Jorge Montes de Oca, Federico Vega, Julio C. Fló, Juan Bonvehí, Pablo Cassará, Jorge Pasquevich, Karina A. Cassataro, Juliana